Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
- PMID: 28341641
- PMCID: PMC5379987
- DOI: 10.1084/jem.20170193
Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
Abstract
A latent reservoir for HIV-1 in resting CD4+ T lymphocytes precludes cure. Mechanisms underlying reservoir stability are unclear. Recent studies suggest an unexpected degree of infected cell proliferation in vivo. T cell activation drives proliferation but also reverses latency, resulting in productive infection that generally leads to cell death. In this study, we show that latently infected cells can proliferate in response to mitogens without producing virus, generating progeny cells that can release infectious virus. Thus, assays relying on one round of activation underestimate reservoir size. Sequencing of independent clonal isolates of replication-competent virus revealed that 57% had env sequences identical to other isolates from the same patient. Identity was confirmed by full-genome sequencing and was not attributable to limited viral diversity. Phylogenetic and statistical analysis suggested that identical sequences arose from in vivo proliferation of infected cells, rather than infection of multiple cells by a dominant viral species. The possibility that much of the reservoir arises by cell proliferation presents challenges to cure.
© 2017 Hosmane et al.
Figures







Comment in
-
HIV: Persistence through division.J Exp Med. 2017 Apr 3;214(4):875-876. doi: 10.1084/jem.20170463. Epub 2017 Mar 27. J Exp Med. 2017. PMID: 28348204 Free PMC article.
Similar articles
-
CD161+ CD4+ T Cells Harbor Clonally Expanded Replication-Competent HIV-1 in Antiretroviral Therapy-Suppressed Individuals.mBio. 2019 Oct 8;10(5):e02121-19. doi: 10.1128/mBio.02121-19. mBio. 2019. PMID: 31594817 Free PMC article.
-
Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2575-E2584. doi: 10.1073/pnas.1720665115. Epub 2018 Feb 26. Proc Natl Acad Sci U S A. 2018. PMID: 29483265 Free PMC article.
-
Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir.Elife. 2020 Sep 29;9:e60933. doi: 10.7554/eLife.60933. Elife. 2020. PMID: 32990219 Free PMC article.
-
Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.Retrovirology. 2018 Feb 13;15(1):21. doi: 10.1186/s12977-018-0404-7. Retrovirology. 2018. PMID: 29433524 Free PMC article. Review.
-
HIV-1 reservoir dynamics in CD4+ T cells.Curr Opin HIV AIDS. 2019 Mar;14(2):108-114. doi: 10.1097/COH.0000000000000521. Curr Opin HIV AIDS. 2019. PMID: 30531293 Review.
Cited by
-
Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA.Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18692-18700. doi: 10.1073/pnas.2006816117. Epub 2020 Jul 20. Proc Natl Acad Sci U S A. 2020. PMID: 32690683 Free PMC article.
-
Advancements in Cell-Based Therapies for HIV Cure.Cells. 2023 Dec 28;13(1):64. doi: 10.3390/cells13010064. Cells. 2023. PMID: 38201268 Free PMC article. Review.
-
HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication.Biomedicines. 2023 Feb 18;11(2):617. doi: 10.3390/biomedicines11020617. Biomedicines. 2023. PMID: 36831153 Free PMC article. Review.
-
Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones.J Clin Invest. 2023 Nov 1;133(21):e171097. doi: 10.1172/JCI171097. J Clin Invest. 2023. PMID: 37698927 Free PMC article.
-
Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir.J Exp Med. 2020 Jul 6;217(7):e20200051. doi: 10.1084/jem.20200051. J Exp Med. 2020. PMID: 32311008 Free PMC article.
References
-
- Archin N.M., Liberty A.L., Kashuba A.D., Choudhary S.K., Kuruc J.D., Crooks A.M., Parker D.C., Anderson E.M., Kearney M.F., Strain M.C., et al. . 2012. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 487:482–485. 10.1038/nature11286 - DOI - PMC - PubMed
-
- Bailey J.R., Sedaghat A.R., Kieffer T., Brennan T., Lee P.K., Wind-Rotolo M., Haggerty C.M., Kamireddi A.R., Liu Y., Lee J., et al. . 2006. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J. Virol. 80:6441–6457. 10.1128/JVI.00591-06 - DOI - PMC - PubMed
-
- Banga R., Procopio F.A., Noto A., Pollakis G., Cavassini M., Ohmiti K., Corpataux J.M., de Leval L., Pantaleo G., and Perreau M.. 2016. PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nat. Med. 22:754–761. 10.1038/nm.4113 - DOI - PubMed
Publication types
MeSH terms
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials